CYP3A5 and pancreatic ductal adenocarcinoma: CYP3A5 has been proposed to be a key mediator of both intrinsic and acquired chemoresistance in pancreatic ductal adenocarcinoma, possibly because of its involvement in tumor cell-autonomous drug detoxification [24, 25].